edison tv
Investment Companies
“Edison is the go-to for a new investor to get full understanding of the investment case and business. Edison’s distribution reaches investors that we want to connect with directly.”
OSE Immunotherapeutics has announced that Marc Le Bozec will transition form interim CEO (which was effective from 2 October 2025) to permanent CEO (effective immediately). The decision was made based on a detailed review of internal and external candidates, and upon recommendation of the Nomination and Compensation Committee. Marc Le Bozec is committed to leading the company in its goals to deliver novel immunotherapies in the fields of immuno-oncology and immuno-inflammation, with a focus on precision medicine and patient centric clinical development.
Investment Companies | Comment
Healthcare | Comment
Healthcare | Comment
Industrials | Comment
Get access to the very latest content matched to your personal investment style.